Sarepta Therapeutics (SRPT) Receivables Refunds (2023 - 2025)
Historic Receivables Refunds for Sarepta Therapeutics (SRPT) over the last 3 years, with Q3 2025 value amounting to $14.3 million.
- Sarepta Therapeutics' Receivables Refunds rose 2519.7% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 2519.7%. This contributed to the annual value of $13.1 million for FY2024, which is 9137.28% up from last year.
- As of Q3 2025, Sarepta Therapeutics' Receivables Refunds stood at $14.3 million, which was up 2519.7% from $7.2 million recorded in Q2 2025.
- Sarepta Therapeutics' Receivables Refunds' 5-year high stood at $14.3 million during Q3 2025, with a 5-year trough of $6.9 million in Q4 2023.
- In the last 3 years, Sarepta Therapeutics' Receivables Refunds had a median value of $8.4 million in 2024 and averaged $9.8 million.
- In the last 5 years, Sarepta Therapeutics' Receivables Refunds skyrocketed by 9137.28% in 2024 and then plummeted by 1391.56% in 2025.
- Quarter analysis of 3 years shows Sarepta Therapeutics' Receivables Refunds stood at $6.9 million in 2023, then surged by 91.37% to $13.1 million in 2024, then increased by 8.89% to $14.3 million in 2025.
- Its Receivables Refunds stands at $14.3 million for Q3 2025, versus $7.2 million for Q2 2025 and $7.0 million for Q1 2025.